131 related articles for article (PubMed ID: 11102894)
21. Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival.
García-Fernández A; Lain JM; Chabrera C; García Font M; Fraile M; Barco I; Torras M; Reñe A; González S; González C; Piqueras M; Veloso E; Cirera L; Pessarrodona A; Giménez N
Breast J; 2015; 21(5):533-7. PubMed ID: 26190560
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas.
Kostianets O; Antoniuk S; Filonenko V; Kiyamova R
Diagn Pathol; 2012 Nov; 7():161. PubMed ID: 23181716
[TBL] [Abstract][Full Text] [Related]
23. HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.
Garrido MA; Rodriguez T; Zinchenko S; Maleno I; Ruiz-Cabello F; Concha Á; Olea N; Garrido F; Aptsiauri N
Immunogenetics; 2018 Nov; 70(10):647-659. PubMed ID: 30145665
[TBL] [Abstract][Full Text] [Related]
24. Back to Basics: Traditional Nottingham Grade Mitotic Counts Alone are Significant in Predicting Survival in Invasive Breast Carcinoma.
Chang JM; McCullough AE; Dueck AC; Kosiorek HE; Ocal IT; Lidner TK; Gray RJ; Wasif N; Northfelt DW; Anderson KS; Pockaj BA
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S509-15. PubMed ID: 26001860
[TBL] [Abstract][Full Text] [Related]
25. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
[TBL] [Abstract][Full Text] [Related]
26. Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma.
Kleinberg L; Flørenes VA; Skrede M; Dong HP; Nielsen S; McMaster MT; Nesland JM; Shih IeM; Davidson B
Virchows Arch; 2006 Jul; 449(1):31-9. PubMed ID: 16541284
[TBL] [Abstract][Full Text] [Related]
27. Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.
Ferns DM; Heeren AM; Samuels S; Bleeker MCG; de Gruijl TD; Kenter GG; Jordanova ES
J Immunother Cancer; 2016; 4():78. PubMed ID: 27895918
[TBL] [Abstract][Full Text] [Related]
28. HLA class I molecules expression: evaluation of different immunocytochemical methods in malignant lesions.
Facoetti A; Capelli E; Nano R
Anticancer Res; 2001; 21(4A):2435-40. PubMed ID: 11724304
[TBL] [Abstract][Full Text] [Related]
29. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of tumor-stroma ratio combined with the immune status of tumors in invasive breast carcinoma.
Vangangelt KMH; van Pelt GW; Engels CC; Putter H; Liefers GJ; Smit VTHBM; Tollenaar RAEM; Kuppen PJK; Mesker WE
Breast Cancer Res Treat; 2018 Apr; 168(3):601-612. PubMed ID: 29273955
[TBL] [Abstract][Full Text] [Related]
31. Topoisomerase II alpha and microtubule-associated protein-tau as a predictive marker in axillary lymph node positive breast cancer.
Won HS; Lee KE; Sung SH; Choi MY; Jo JY; Nam EM; Mun YC; Seong CM; Lee SN
Tumori; 2014; 100(1):80-6. PubMed ID: 24675496
[TBL] [Abstract][Full Text] [Related]
32. GATA3 expression and its relationship with clinicopathological parameters in invasive breast carcinomas.
Cakir A; Isik Gonul I; Ekinci O; Cetin B; Benekli M; Uluoglu O
Pathol Res Pract; 2017 Mar; 213(3):227-234. PubMed ID: 28215639
[TBL] [Abstract][Full Text] [Related]
33. Total loss of MHC class I is an independent indicator of good prognosis in breast cancer.
Madjd Z; Spendlove I; Pinder SE; Ellis IO; Durrant LG
Int J Cancer; 2005 Nov; 117(2):248-55. PubMed ID: 15900607
[TBL] [Abstract][Full Text] [Related]
34. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
[TBL] [Abstract][Full Text] [Related]
35. BAG-1/SODD, HSP70, and HSP90 are potential prognostic markers of poor survival in node-negative breast carcinoma.
Davidson B; Valborg Reinertsen K; Trinh D; Reed W; Bøhler PJ
Hum Pathol; 2016 Aug; 54():64-73. PubMed ID: 27038683
[TBL] [Abstract][Full Text] [Related]
36. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
37. Analysis of HLA-G gene polymorphism and protein expression in invasive breast ductal carcinoma.
Ramos CS; Gonçalves AS; Marinho LC; Gomes Avelino MA; Saddi VA; Lopes AC; Simões RT; Wastowski IJ
Hum Immunol; 2014 Jul; 75(7):667-72. PubMed ID: 24759678
[TBL] [Abstract][Full Text] [Related]
38. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
[TBL] [Abstract][Full Text] [Related]
39. Anti-p53 in breast cancer: concordance of different assay procedures and association with p53 antigen expression.
Volkmann M; Sinn HP; Gaugel D; Frey M; Hajjar Y; Ludwig J; Hänsel S; Bastert G; Wallwiener D; Fiehn W; Zentgraf H; Huober J
Oncology; 2002; 63(3):297-305. PubMed ID: 12381910
[TBL] [Abstract][Full Text] [Related]
40. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
Chen Y; Song J; Jiang Y; Yu C; Ma Z
Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
